Nasdaq Surges 100 Points; Crude Oil Falls Sharply
U.S. stocks traded higher midway through trading, with the Nasdaq Composite adding more than 100 points on Wednesday.
UiPath Faces Price Target Cuts By Analysts Following Q2 Results, Shares Plummet
UiPath Inc (NYSE: PATH) reported upbeat results for its second quarter, but issued weak guidance.
US Stocks Edge Higher; Dow Rises 50 Points
U.S. stocks traded slightly higher this morning, with the Dow Jones adding more than 50 points on Wednesday.
Truist Securities Maintains Buy on UiPath, Lowers Price Target to $25
Truist Securities analyst Terry Tillman maintains UiPath (NYSE:PATH) with a Buy and lowers the price target from $45 to $25.
BMO Capital Maintains Market Perform on UiPath, Lowers Price Target to $15
BMO Capital analyst Keith Bachman maintains UiPath (NYSE:PATH) with a Market Perform and lowers the price target from $21 to $15.
Why Is UiPath Stock Down 20% Today?
UiPath Inc (NYSE: PATH) shares are trading lower Wednesday after the company reported financial results and issued weak guidance.
Cowen & Co. Maintains Outperform on UiPath, Lowers Price Target to $20
Cowen & Co. analyst Bryan Bergin maintains UiPath (NYSE:PATH) with a Outperform and lowers the price target from $27 to $20.
Why Coupa Software Is Trading Higher By Over 12%; Here Are 24 Stocks Moving Premarket
Gainers
Biophytis S.A. (NASDAQ: BPTS) shares rose 41.5% to $1.33 in pre-market trading after the company announced data on Covid treatment.